Published in Allergy Asthma Immunol Res on September 21, 2011
IgE and mast cells in allergic disease. Nat Med (2012) 3.14
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol (2014) 0.92
New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther (2013) 0.88
Highly Cytokinergic IgE Antibodies and Autoimmune Mechanisms. Allergy Asthma Immunol Res (2012) 0.82
IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol (2013) 0.81
Cytokine regulation during epidermal differentiation and barrier formation. J Invest Dermatol (2014) 0.80
7,3',4'-Trihydroxyisoflavone Ameliorates the Development of Dermatophagoides farinae-Induced Atopic Dermatitis in NC/Nga Mice. Evid Based Complement Alternat Med (2013) 0.77
Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis. Proc Natl Acad Sci U S A (2016) 0.77
Prevention of atopic dermatitis. F1000 Med Rep (2012) 0.76
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study. Contact Dermatitis (2013) 0.76
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci (2016) 0.75
Increased epidermal filaggrin in chronic idiopathic urticaria is associated with severity of urticaria. Ann Allergy Asthma Immunol (2014) 0.75
Atopic dermatitis phenotypes in childhood. Ital J Pediatr (2014) 0.75
Esophageal human β-defensin expression in eosinophilic esophagitis. Pediatr Res (2013) 0.75
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99
The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol (2005) 6.27
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest (1998) 3.85
The skin: an indispensable barrier. Exp Dermatol (2008) 3.54
The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell (1977) 3.00
Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol (2007) 2.82
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2007) 2.79
The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol (2008) 2.53
The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem (1995) 2.39
Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int Rev Cytol (1981) 2.31
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol (2000) 2.22
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol (2006) 2.22
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol (2009) 2.20
Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol (2010) 2.20
Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol (2008) 2.11
Atopic dermatitis. Ann Dermatol (2010) 2.07
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol (2009) 2.03
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009) 2.00
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol (2009) 1.99
Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol (2009) 1.91
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2008) 1.89
Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts. J Allergy Clin Immunol (2011) 1.84
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol (2007) 1.77
A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol (2006) 1.72
Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol (1986) 1.71
The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69
Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol (2007) 1.57
Assembly of the epidermal cornified cell envelope. J Cell Sci (2001) 1.51
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol (2009) 1.50
Skin barrier function and allergic risk. Nat Genet (2006) 1.50
Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol (2007) 1.45
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol (2009) 1.43
The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol (1994) 1.42
The genetics of atopic dermatitis. J Allergy Clin Immunol (2006) 1.39
The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol (2008) 1.36
Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J Invest Dermatol (2006) 1.34
Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol (2008) 1.27
Biosynthetic pathways of filaggrin and loricrin--two major proteins expressed by terminally differentiated epidermal keratinocytes. J Struct Biol (1991) 1.24
Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol (2008) 1.23
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2009) 1.22
The stratum corneum: structure and function in health and disease. Dermatol Ther (2004) 1.21
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy (2010) 1.19
Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol (2008) 1.12
Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol (2008) 1.12
Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol (2007) 1.08
Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol (2009) 1.02
Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis. Allergy (2010) 0.94
Quasi-normal cornified cell envelopes in loricrin knockout mice imply the existence of a loricrin backup system. J Invest Dermatol (2002) 0.94
Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol (2005) 0.93
A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. J Drugs Dermatol (2007) 0.89
Caspase-14 and epidermis maturation. Nat Cell Biol (2007) 0.82
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol (2009) 0.81